Breaking News Instant updates and real-time market news.

2020-11-25 04:55:00 RBGLY Reckitt Benckiser $0.00 / + (+0.00%) 04:55 11/25/20 11/25 04:55 11/25/20 04:55	Reckitt Benckiser management to meet virtually with JPMorgan Virtual Meetings to be held November 24-25 hosted by JPMorgan.	25 Nov
RBGLY Reckitt Benckiser $0.00 / + (+0.00%) 11/19/20 Jefferies Reckitt Benckiser downgraded to Underperform from Hold at Jefferies 11/11/20 Credit Suisse Reckitt Benckiser upgraded to Outperform from Neutral at Credit Suisse 11/06/20 RBC Capital Reckitt Benckiser upgraded to Sector Perform from Underperform at RBC Capital 10/23/20 Berenberg Reckitt Benckiser price target raised to 9,100 GBp from 9,000 GBp at Berenberg

2020-11-25 04:55:00

RBGLY

Reckitt Benckiser

$0.00 / + (+0.00%)

04:55

11/25/20

11/25

04:55

11/25/20

04:55

Reckitt Benckiser management to meet virtually with JPMorgan

Virtual Meetings to be held November 24-25 hosted by JPMorgan.

25
Nov

RBGLY Reckitt Benckiser

$0.00 / + (+0.00%)

11/19/20 Jefferies: Reckitt Benckiser downgraded to Underperform from Hold at Jefferies

11/11/20 Credit Suisse: Reckitt Benckiser upgraded to Outperform from Neutral at Credit Suisse

11/06/20 RBC Capital: Reckitt Benckiser upgraded to Sector Perform from Underperform at RBC Capital

10/23/20 Berenberg: Reckitt Benckiser price target raised to 9,100 GBp from 9,000 GBp at Berenberg

TODAY'S FREE FLY STORIES

Earnings	Broadwind expects to report Q4 revenue $40M, consensus $44.25M » 07:03 01/22/21 01/22 07:03 01/22/21 07:03 BWEN Broadwind $10.50 / +0.12 (+1.16%) Broadwind issued… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BWEN Broadwind $10.50 / +0.12 (+1.16%) 08/31/20 Broadwind announces approx. $21M in wind tower orders from existing customer BWEN Broadwind $10.50 / +0.12 (+1.16%) 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital 12/15/20 Roth Capital Solar tax credit extension would be positive surprise, says Roth Capital 09/09/20 Johnson Rice Broadwind initiated with a Buy at Johnson Rice 07/22/20 H.C. Wainwright Wind 'a big beneficiary' in NY renewable energy expansion, says H.C. Wainwright BWEN Broadwind $10.50 / +0.12 (+1.16%) 11/04/20 Broadwind sees Q4 revenue $43M-$46M, consensus $46.24M 11/04/20 Broadwind Energy reports Q3 EPS (6c), consensus (6c) 08/31/20 Broadwind sees 2020 revenue approx. $200M, consensus $203.74M 08/05/20 Broadwind Energy reports Q2 EPS 3c, consensus 2c BWEN Broadwind $10.50 / +0.12 (+1.16%) 07/22/20 NY issues record-breaking solicitations for renewable energy, PVTech reports BWEN Broadwind $10.50 / +0.12 (+1.16%) 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 08/31/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	Humanigen announces expansion of CRADA for lenzilumab development » 07:03 01/22/21 01/22 07:03 01/22/21 07:03 HGEN Humanigen $18.81 / -0.13 (-0.69%) Humanigen announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options HGEN Humanigen $18.81 / -0.13 (-0.69%) 01/20/21 Humanigen changes primary endpoint of lenzilumab trial in COVID-19 patients 01/10/21 Humanigen, EVERSANA announce partnership to support Lenzilumab launch 12/28/20 Humanigen issued patent for lenzilumab by USPTO 12/17/20 Humanigen completes enrollment in ifabotuzumab bioimaging study HGEN Humanigen $18.81 / -0.13 (-0.69%) 01/20/21 Jefferies Jefferies reads Humanigen COVID-19 trial change as 'sign of confidence' 12/23/20 National Securities Humanigen initiated with a Buy at National Securities 12/22/20 Fly Intel: Top five analyst initiations 12/22/20 Jefferies Humanigen initiated with a Buy at Jefferies HGEN Humanigen $18.81 / -0.13 (-0.69%) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 18 Sep HGEN Humanigen $18.81 / -0.13 (-0.69%) 12/17/20 Fly Intel: Wall Street's top stories for Thursday 12/17/20 Fly Intel: Wall Street's top stories at midday 11/06/20 Fly Intel: Wall Street's top stories for Friday 11/06/20 Fly Intel: Wall Street's top stories at midday HGEN Humanigen $18.81 / -0.13 (-0.69%) 09/30/20 Thirteen new option listings and two option delistings on September 30th
Earnings	Huntington Bancshares sees FY21 revenue up about 1%-3%, consensus $5.89B » 07:02 01/22/21 01/22 07:02 01/22/21 07:02 HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) For FY21: Full-year… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 12/14/20 TCF Financial to merge into Huntington Bancshares in to all-stock deal 11/30/20 Huntington Bancshares to upgrade entire ATM network, replace 400 machines by YE 11/22/20 Fly Intel: Top five weekend stock stories 10/22/20 Huntington Banc cautiously optimistic C&I loan growth to improve later this year HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 01/13/21 Piper Sandler PNC Financial downgraded to Neutral from Overweight at Piper Sandler 01/06/21 Wedbush Huntington Bancshares added to Best Ideas List at Wedbush 01/06/21 Deutsche Bank Huntington Bancshares price target raised to $14 from $10.50 at Deutsche Bank 01/05/21 Piper Sandler TCF Financial upgraded to Overweight from Neutral at Piper Sandler HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 07:01 Today Huntington Bancshares reports Q4 EPS 27c, consensus 29c 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/22/20 Huntington Bancshares sees FY20 revenue up 3.0%-3.5%, consensus $4.78B HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 12/13/20 Huntington, TCF Financial near all-stock merger deal, WSJ reports 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 12/14/20 Fly Intel: Pre-market Movers 10/26/20 Apple coverage reinstatement, KeyCorp downgrade among top calls on Wall Street 07/23/20 Fly Intel: Pre-market Movers 08:30 Today Huntington Bancshares - HBAN HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 11/04/20 Unusually active option classes on open November 4th
Recommendations	Intuitive Surgical price target raised to $879 from $841 at Wells Fargo » 07:02 01/22/21 01/22 07:02 01/22/21 07:02 ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Intuitive Surgical says overall procedure growth was 6% in Q4 10/27/20 Intuitive Surgical launches $100M venture capital fund 10/15/20 Intuitive Surgical slides 2.8% to $720 per share after Q3 results 10/15/20 Intuitive Surgical's first 9 months of 2020 saw 'significant impact' from COVID ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 06:29 Today Oppenheimer Intuitive Surgical price target raised to $410 from $365 at Oppenheimer 05:02 Today Piper Sandler Intuitive Surgical price target raised to $730 from $680 at Piper Sandler 12/15/20 Morgan Stanley Intuitive Surgical downgraded to Equal Weight on valuation at Morgan Stanley 12/15/20 Morgan Stanley Intuitive Surgical downgraded to Equal Weight from Overweight at Morgan Stanley ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Intuitive Surgical reports Q4 EPS $3.58, consensus $3.12 01/21/21 Notable companies reporting after market close 01/13/21 Intuitive Surgical sees 2020 revenue $4.36B, consensus $4.27B 01/13/21 Intuitive Surgical sees Q4 revenue $1.33B, consensus $1.23B ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Fly Intel: After-Hours Movers 10/15/20 Fly Intel: After-Hours Movers ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 11/12/20 Early notable gainers among liquid option names on November 12th 10/15/20 Intuitive Surgical options imply 5.8% move in share price post-earnings
Upgrade	EQ Inc. upgraded to Buy from Speculative Buy at Canaccord » 07:01 01/22/21 01/22 07:01 01/22/21 07:01 CYPXF EQ Inc. $0.00 / + (+0.00%) Canaccord analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CYPXF EQ Inc. $0.00 / + (+0.00%) 09/17/20 Canaccord EQ Inc initiated with a Speculative Buy at Canaccord

Earnings	Huntington Bancshares reports Q4 EPS 27c, consensus 29c » 07:01 01/22/21 01/22 07:01 01/22/21 07:01 HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) Reports Q4 net interest… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 12/14/20 TCF Financial to merge into Huntington Bancshares in to all-stock deal 11/30/20 Huntington Bancshares to upgrade entire ATM network, replace 400 machines by YE 11/22/20 Fly Intel: Top five weekend stock stories 10/22/20 Huntington Banc cautiously optimistic C&I loan growth to improve later this year HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 01/13/21 Piper Sandler PNC Financial downgraded to Neutral from Overweight at Piper Sandler 01/06/21 Wedbush Huntington Bancshares added to Best Ideas List at Wedbush 01/06/21 Deutsche Bank Huntington Bancshares price target raised to $14 from $10.50 at Deutsche Bank 01/05/21 Piper Sandler TCF Financial upgraded to Overweight from Neutral at Piper Sandler HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/22/20 Huntington Bancshares sees FY20 revenue up 3.0%-3.5%, consensus $4.78B 10/22/20 Huntington Bancshares reports Q3 EPS 27c, consensus 25c HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 12/13/20 Huntington, TCF Financial near all-stock merger deal, WSJ reports 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 12/14/20 Fly Intel: Pre-market Movers 10/26/20 Apple coverage reinstatement, KeyCorp downgrade among top calls on Wall Street 07/23/20 Fly Intel: Pre-market Movers 08:30 Today Huntington Bancshares - HBAN HBAN Huntington Bancshares $14.51 / -0.18 (-1.23%) 11/04/20 Unusually active option classes on open November 4th
Recommendations	SVB Financial price target raised to $400 from $325 at Wells Fargo » 07:01 01/22/21 01/22 07:01 01/22/21 07:01 SIVB SVB Financial / + Wells Fargo analyst Jared… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SIVB SVB Financial / + 01/05/21 HoldCo expresses concerns regarding Boston Private Financial, SVB Financial deal 01/04/21 SVB Financial to acquire Boston Private Financial in $900M cash and stock deal 12/08/20 Clearbanc, Silicon Valley Bank partner on new capital program 11/30/20 SVB Financial to acquire WestRiver Group's debt investment business SIVB SVB Financial / + 01/08/21 Oppenheimer Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move' 01/05/21 DA Davidson SVB Financial price target raised to $400 from $365 at DA Davidson 01/05/21 Raymond James SVB Financial price target raised to $440 from $325 at Raymond James 01/05/21 RBC Capital SVB Financial price target raised to $437 from $320 at RBC Capital SIVB SVB Financial / + 01/21/21 SVB Financial reports Q4 EPS $7.40, consensus $3.83 10/23/20 SVB Financial reports Q3 EPS $8.47, consensus $5.14 07/23/20 SVB Financial reports Q2 EPS $4.42, consensus $3.11 SIVB SVB Financial / + 01/21/21 Fly Intel: After-Hours Movers 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday
Recommendations	IBM miss in software elevates concerns, says Morgan Stanley » 07:01 01/22/21 01/22 07:01 01/22/21 07:01 IBM IBM $131.80 / +1.72 (+1.32%) Following IBM's Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 IBM down 6.5% at $123.24 after Q4 earnings, conference call outlook 01/21/21 IBM sees FY21 'revenue growth based on current spot rates' 01/21/21 IBM NewCo CEO Martin Schroeter says company has 'tremendous potential' 01/21/21 IBM CFO says optimizing NewCo to have a 'leaner' operating model IBM IBM $131.80 / +1.72 (+1.32%) 10/20/20 Morgan Stanley Morgan Stanley continues to view IBM as 'a 2022 stock' 10/20/20 Citi IBM is 'getting even more complex,' says Citi 10/20/20 BMO Capital IBM price target lowered to $138 from $140 at BMO Capital 10/09/20 Morgan Stanley IBM price target raised to $140 from $128 at Morgan Stanley IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 IBM reports Q4 Cloud & Cognitive Software revenue $6.8B, down 4.5% 01/21/21 IBM reports Q4 adjusted EPS $2.07, consensus $1.79 01/21/21 Notable companies reporting after market close 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% IBM IBM $131.80 / +1.72 (+1.32%) 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/06/21 IBM restructuring sales organization, WSJ reports 11/25/20 IBM to eliminate 10,000 positions in Europe ahead of unit sale, Bloomberg says 10/11/20 IBM split might not mean speedy recovery, WSJ says IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 Fly Intel: After-Hours Movers 01/21/21 Fly Intel: What to watch in IBM's earnings report 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 IBM options imply 6.3% move in share price post-earnings 01/05/21 Unusually active option classes on open January 5th 10/30/20 IBM call volume above normal and directionally bullish 10/19/20 IBM options imply 6.1% move in share price post-earnings
Hot Stocks	Nasdaq appoints Jeremy Skule Chief Strategy Officer » 07:00 01/22/21 01/22 07:00 01/22/21 07:00 NDAQ Nasdaq $141.44 / -2.27 (-1.58%) Nasdaq has appointed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NDAQ Nasdaq $141.44 / -2.27 (-1.58%) 01/14/21 Nasdaq says trading halted in Generations Bancorp NY, Inc. 01/13/21 Nasdaq pauses political donations for next several months 01/06/21 Nasdaq led all exchanges in 2020 equity options trading 12/17/20 Nasdaq welcomed 300 IPOs, 21 exchange transfers in 2020 NDAQ Nasdaq $141.44 / -2.27 (-1.58%) 01/19/21 Nasdaq upgraded to Buy at UBS on robust volume and organic growth trends 01/19/21 UBS Nasdaq upgraded to Buy from Neutral at UBS 01/13/21 Deutsche Bank Nasdaq price target raised to $163 from $159 at Deutsche Bank 01/12/21 Barclays Nasdaq price target raised to $155 from $147 at Barclays NDAQ Nasdaq $141.44 / -2.27 (-1.58%) 10/21/20 Nasdaq reports Q3 adj. EPS $1.58, consensus $1.45 07/22/20 Nasdaq reports Q2 adj. EPS $1.54, consensus $1.44 NDAQ Nasdaq $141.44 / -2.27 (-1.58%) 09/29/20 Wall Street data pricing new target for Trump antitrust cop, Bloomberg says 09/29/20 DOJ's Delrahim 'paying close attention' to exchange data pricing, Bloomberg says 09/23/20 Nasdaq, CME plan to launch water futures contract this year, WSJ reports 08/20/20 Airbnb confidentially files paperwork for IPO, WSJ reports NDAQ Nasdaq $141.44 / -2.27 (-1.58%) 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Morgan Stanley sees needed AML fix potentially slowing Square's Cash App growth 11/19/20 Fly Intel: Wall Street's top stories at midday 11/19/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference 01/27/21 Nasdaq - NDAQ 02/02/21 Adena T.Friedman NDAQ Nasdaq $141.44 / -2.27 (-1.58%) 12/07/20 Early notable gainers among liquid option names on December 7th
Hot Stocks	Schlumberger sees 'clear path' to double-digit margins in North America in 2021 » 06:59 01/22/21 01/22 06:59 01/22/21 06:59 SLB Schlumberger $24.18 / -1.16 (-4.58%) Schlumberger CEO Olivier… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SLB Schlumberger $24.18 / -1.16 (-4.58%) 06:55 Today Schlumberger sees FY21 capital investment $1.5B-$1.7B 06:52 Today Schlumberger CEO says 'concluded the year posting very strong fourth-quarter' 06:50 Today Schlumberger reports Q4 cash flow from operations $878M, free cash flow $554M 01/11/21 Schlumberger announces European Commission approval for formation of Genvia JV SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/18/20 JPMorgan Schlumberger price target raised to $21 from $19 at JPMorgan 12/15/20 Citi Schlumberger price target raised to $30 from $25 at Citi 12/10/20 HSBC Schlumberger downgraded to Reduce from Hold at HSBC 11/30/20 Susquehanna Susquehanna raises targets across Oilfield Services on cyclical rebound SLB Schlumberger $24.18 / -1.16 (-4.58%) 06:50 Today Schlumberger reports Q4 adjusted EPS 22c, consensus 17c 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/16/20 Schlumberger reports Q3 adjusted EPS 16c, consensus 12c SLB Schlumberger $24.18 / -1.16 (-4.58%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says SLB Schlumberger $24.18 / -1.16 (-4.58%) 10/16/20 Fly Intel: Pre-market Movers 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 09/01/20 Fly Intel: Wall Street's top stories at midday 07/24/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 08:30 Today Schlumberger - SLB SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/10/20 Schlumberger call volume above normal and directionally bullish 11/16/20 Schlumberger call volume above normal and directionally bullish 10/16/20 Unusually active option classes on open October 16th 10/08/20 Schlumberger call volume above normal and directionally bullish

Recommendations	Intel price target raised to $68 from $60 at Mizuho » 06:59 01/22/21 01/22 06:59 01/22/21 06:59 INTC Intel $62.47 / +3.81 (+6.50%) Mizuho analyst Vijay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel announces 5% increase to quarterly cash dividend 01/21/21 Intel up 7% after early release of Q4 results 01/17/21 Fly Intel: Top five weekend stock stories 01/13/21 Dan Loeb says Intel CEO Bob Swan did 'right thing' to step aside INTC Intel $62.47 / +3.81 (+6.50%) 06:58 Today RBC Capital Intel price target raised to $47 from $40 at RBC Capital 06:23 Today Citi Intel shares to trade up in near-term, not mid-term, says Citi 06:14 Today Barclays Intel manufacturing commitment show 'no quick fix,' says Barclays 01/20/21 Susquehanna Intel investors watching long term strategic direction, says Susquehanna INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel sees Q1 EPS $1.10, consensus 93c 01/21/21 Intel reports Q4 EPS $1.52, consensus $1.10 01/21/21 Notable companies reporting after market close 01/13/21 Intel sees Q4 revenue and EPS to exceed prior guidance INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel says hacker gained access to financially sensitive data, FT reports 01/17/21 Trump admin slams China's Huawei, halting shipments from Intel, Reuters says 01/16/21 Intel rebound will still take time, Barron's says 01/15/21 Intel may fully advance to 10nm in 2021, DigiTimes reports INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Fly Intel: What to watch in Intel's earnings report 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/14/21 AMD slips as analyst says sell on Gelsinger's return to Intel INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel options imply 9.0% move in share price post-earnings 01/13/21 Early notable gainers among liquid option names on January 13th 01/13/21 Intel call volume above normal and directionally bullish 01/04/21 Intel call volume above normal and directionally bullish
Recommendations	Intel price target raised to $47 from $40 at RBC Capital » 06:58 01/22/21 01/22 06:58 01/22/21 06:58 INTC Intel $62.47 / +3.81 (+6.50%) RBC Capital analyst Mitch… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel announces 5% increase to quarterly cash dividend 01/21/21 Intel up 7% after early release of Q4 results 01/17/21 Fly Intel: Top five weekend stock stories 01/13/21 Dan Loeb says Intel CEO Bob Swan did 'right thing' to step aside INTC Intel $62.47 / +3.81 (+6.50%) 06:23 Today Citi Intel shares to trade up in near-term, not mid-term, says Citi 06:14 Today Barclays Intel manufacturing commitment show 'no quick fix,' says Barclays 01/20/21 Susquehanna Intel investors watching long term strategic direction, says Susquehanna 01/15/21 Evercore ISI Evercore adds Dell Technologies to tactical Outperform list, ups target to $85 INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel sees Q1 EPS $1.10, consensus 93c 01/21/21 Intel reports Q4 EPS $1.52, consensus $1.10 01/21/21 Notable companies reporting after market close 01/13/21 Intel sees Q4 revenue and EPS to exceed prior guidance INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel says hacker gained access to financially sensitive data, FT reports 01/17/21 Trump admin slams China's Huawei, halting shipments from Intel, Reuters says 01/16/21 Intel rebound will still take time, Barron's says 01/15/21 Intel may fully advance to 10nm in 2021, DigiTimes reports INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Fly Intel: What to watch in Intel's earnings report 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/14/21 AMD slips as analyst says sell on Gelsinger's return to Intel INTC Intel $62.47 / +3.81 (+6.50%) 01/21/21 Intel options imply 9.0% move in share price post-earnings 01/13/21 Early notable gainers among liquid option names on January 13th 01/13/21 Intel call volume above normal and directionally bullish 01/04/21 Intel call volume above normal and directionally bullish
Recommendations	Consolidated Edison price target lowered to $68 from $71 at Mizuho » 06:57 01/22/21 01/22 06:57 01/22/21 06:57 ED Consolidated Edison $69.16 / -0.78 (-1.12%) Mizuho analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ED Consolidated Edison $69.16 / -0.78 (-1.12%) 01/21/21 Consolidated Edison raises quarterly dividend to 77.5c from 76.5c per share 10/05/20 Itron, Con Ed confirm, NYS affirmed its consent approval for Itron ERT module 09/17/20 Consolidated Edison CEO John McAvoy to retire, Tim Cawley to succeed in 2021 08/13/20 NY PSC announces $10.75M settlement with Con Edison ED Consolidated Edison $69.16 / -0.78 (-1.12%) 06:27 Today RBC Capital Consolidated Edison price target lowered to $77 from $80 at RBC Capital 01/21/21 Evercore ISI Consolidated Edison downgraded to Underperform from In Line at Evercore ISI 11/18/20 Barclays Consolidated Edison price target raised to $83 from $74 at Barclays 11/12/20 Mizuho Consolidated Edison price target raised to $83 from $72 at Mizuho ED Consolidated Edison $69.16 / -0.78 (-1.12%) 01/21/21 Consolidated Edison sees FY20 EPS at low end of prior $4.15-$4.30 target range 11/05/20 Consolidated Edison narrows FY20 adj. EPS view to $4.15-$4.30 from $4.15-$4.35 11/05/20 Consolidated Edison reports Q3 adjusted EPS $1.48, consensus $1.50 11/05/20 Notable companies reporting after market close 02 Dec ED Consolidated Edison $69.16 / -0.78 (-1.12%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street ED Consolidated Edison $69.16 / -0.78 (-1.12%) 09/17/20 Consolidated Edison call volume above normal and directionally bullish
Downgrade	Sage Therapeutics cut to Market Perform at BMO Capital on valuation » 06:56 01/22/21 01/22 06:56 01/22/21 06:56 SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/07/21 Sage Therapeutics plans to advance SAGE-319, SAGE-421 to preclinical studies 12/16/20 Sage Therapeutics names Barry Greene as CEO 11/27/20 Sage Therapeutics trading resumes 11/27/20 Sage Therapeutics to resume trading at 8 am ET SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 05:08 Today BMO Capital Sage Therapeutics downgraded to Market Perform from Outperform at BMO Capital 01/19/21 Wedbush Sage Therapeutics price target raised to $98 from $83 at Wedbush 01/04/21 Sage Therapeutics downgraded to Sector Perform at RBC Capital on valuation 01/04/21 Guggenheim Sage Therapeutics upgraded to Buy from Neutral at Guggenheim SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 11/05/20 Sage Therapeutics reports Q3 EPS ($2.03), consensus ($2.39) 08/10/20 Sage Therapeutics reports Q2 EPS ($2.63), consensus ($2.66) SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 12/04/20 Delta, United, Boeing downgrades among today's top calls on Wall Street 11/27/20 Fly Intel: Wall Street's top stories for Friday 11/27/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference
Hot Stocks	Schlumberger sees FY21 capital investment $1.5B-$1.7B » 06:55 01/22/21 01/22 06:55 01/22/21 06:55 SLB Schlumberger $24.18 / -1.16 (-4.58%) Capital investment in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SLB Schlumberger $24.18 / -1.16 (-4.58%) 06:52 Today Schlumberger CEO says 'concluded the year posting very strong fourth-quarter' 06:50 Today Schlumberger reports Q4 cash flow from operations $878M, free cash flow $554M 01/11/21 Schlumberger announces European Commission approval for formation of Genvia JV 10/16/20 Schlumberger falls -7.8% SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/18/20 JPMorgan Schlumberger price target raised to $21 from $19 at JPMorgan 12/15/20 Citi Schlumberger price target raised to $30 from $25 at Citi 12/10/20 HSBC Schlumberger downgraded to Reduce from Hold at HSBC 11/30/20 Susquehanna Susquehanna raises targets across Oilfield Services on cyclical rebound SLB Schlumberger $24.18 / -1.16 (-4.58%) 06:50 Today Schlumberger reports Q4 adjusted EPS 22c, consensus 17c 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/16/20 Schlumberger reports Q3 adjusted EPS 16c, consensus 12c SLB Schlumberger $24.18 / -1.16 (-4.58%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says SLB Schlumberger $24.18 / -1.16 (-4.58%) 10/16/20 Fly Intel: Pre-market Movers 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 09/01/20 Fly Intel: Wall Street's top stories at midday 07/24/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 08:30 Today Schlumberger - SLB SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/10/20 Schlumberger call volume above normal and directionally bullish 11/16/20 Schlumberger call volume above normal and directionally bullish 10/16/20 Unusually active option classes on open October 16th 10/08/20 Schlumberger call volume above normal and directionally bullish

Recommendations	AB InBev price target raised to EUR 57 from EUR 56 at HSBC » 06:55 01/22/21 01/22 06:55 01/22/21 06:55 BUD AB InBev $67.80 / -0.49 (-0.72%) HSBC analyst Carlos Laboy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BUD AB InBev $67.80 / -0.49 (-0.72%) 12/23/20 Apollo-led group to acquire 49.9% stake in AB InBev U.S. metal container plants 12/08/20 Cemtrex announces engagements with HBO Max, Modelo USA 10/29/20 AB InBev says consumers returning to trusted brands 10/29/20 AB InBev says had share gains in most key markets in Q3 BUD AB InBev $67.80 / -0.49 (-0.72%) 01/21/21 Fly Intel: Top five analyst downgrades 01/21/21 Societe Generale AB InBev downgraded to Sell from Hold at Societe Generale 01/15/21 Berenberg AB InBev price target lowered to EUR 72.10 from EUR 75.70 at Berenberg 01/15/21 Deutsche Bank AB InBev price target lowered to EUR 55 from EUR 60 at Deutsche Bank BUD AB InBev $67.80 / -0.49 (-0.72%) 10/29/20 AB InBev reports Q3 normalized EPS 79c, consensus 69c 09/28/20 Diageo says outlook for first half of fiscal 21 has improved since year-end 07/30/20 AB InBev reports Q2 normalized EPS 46c, consensus 24c 07/29/20 Notable companies reporting before tomorrow's open BUD AB InBev $67.80 / -0.49 (-0.72%) 09/08/20 AB InBev starts search for next CEO to replace Carlos Brito, FT reports 08/05/20 AB InBev, Heineken pause South Africa projects amid alcohol ban, Bloomberg says BUD AB InBev $67.80 / -0.49 (-0.72%) 07/30/20 Walmart, Target initiations among today's top calls on Wall Street 07/30/20 Fly Intel: Pre-market Movers 02/25/21 AB InBev - BUD BUD AB InBev $67.80 / -0.49 (-0.72%) 12/17/20 Unusually active option classes on open December 17th 11/06/20 Anheuser Busch put volume heavy and directionally bearish 10/26/20 Largest borrow rate increases among liquid names 10/21/20 Anheuser Busch put volume heavy and directionally bearish
Recommendations	TAL Education price target raised to $108 from $99 at UBS » 06:52 01/22/21 01/22 06:52 01/22/21 06:52 TAL TAL Education $78.02 / +10.29 (+15.19%) UBS analyst Felix Liu… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TAL TAL Education $78.02 / +10.29 (+15.19%) 01/21/21 TAL Education rises 13.8% 12/28/20 TAL Education announces $3.3B private placement with Silver Lake-led investors TAL TAL Education $78.02 / +10.29 (+15.19%) 05:35 Today CICC TAL Education upgraded to Outperform from Market Perform at CICC 05:29 Today Credit Suisse TAL Education downgraded to Neutral from Outperform at Credit Suisse 12/30/20 Credit Suisse Credit Suisse cuts TAL target to $79 on margin pressure from online competition 12/29/20 CLSA TAL Education now has 'war chest' to fight competition, says CLSA TAL TAL Education $78.02 / +10.29 (+15.19%) 01/21/21 TAL Education sees Q4 revenue $1.18B-$1.2B, consensus $1.17B 01/21/21 TAL Education reports Q3 EPS 2c, consensus 7c 10/22/20 TAL Education sees Q3 revenue $1.06B-$1.09B, consensus $1.14B 10/22/20 TAL Education reports Q2 EPS 8c, consensus 12c TAL TAL Education $78.02 / +10.29 (+15.19%) 08/07/20 Citon says authorities given info to end GSX Techedu 'charade' TAL TAL Education $78.02 / +10.29 (+15.19%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday TAL TAL Education $78.02 / +10.29 (+15.19%) 09/03/20 Tal Education Group put volume heavy and directionally bearish
Hot Stocks	Schlumberger CEO says 'concluded the year posting very strong fourth-quarter' » 06:52 01/22/21 01/22 06:52 01/22/21 06:52 SLB Schlumberger $24.18 / -1.16 (-4.58%) Schlumberger CEO Olivier… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SLB Schlumberger $24.18 / -1.16 (-4.58%) 06:50 Today Schlumberger reports Q4 cash flow from operations $878M, free cash flow $554M 01/11/21 Schlumberger announces European Commission approval for formation of Genvia JV 10/16/20 Schlumberger falls -7.8% 10/16/20 Schlumberger: Conditions set for continued momentum in North America in Q4 SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/18/20 JPMorgan Schlumberger price target raised to $21 from $19 at JPMorgan 12/15/20 Citi Schlumberger price target raised to $30 from $25 at Citi 12/10/20 HSBC Schlumberger downgraded to Reduce from Hold at HSBC 11/30/20 Susquehanna Susquehanna raises targets across Oilfield Services on cyclical rebound SLB Schlumberger $24.18 / -1.16 (-4.58%) 06:50 Today Schlumberger reports Q4 adjusted EPS 22c, consensus 17c 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/16/20 Schlumberger reports Q3 adjusted EPS 16c, consensus 12c SLB Schlumberger $24.18 / -1.16 (-4.58%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says SLB Schlumberger $24.18 / -1.16 (-4.58%) 10/16/20 Fly Intel: Pre-market Movers 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 09/01/20 Fly Intel: Wall Street's top stories at midday 07/24/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 08:30 Today Schlumberger - SLB SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/10/20 Schlumberger call volume above normal and directionally bullish 11/16/20 Schlumberger call volume above normal and directionally bullish 10/16/20 Unusually active option classes on open October 16th 10/08/20 Schlumberger call volume above normal and directionally bullish
Hot Stocks	International Game subsidiary signs seven-year contract extension with SVL » 06:51 01/22/21 01/22 06:51 01/22/21 06:51 IGT International Game $17.90 / -0.45 (-2.45%) International Game… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options IGT International Game $17.90 / -0.45 (-2.45%) 01/05/21 International Game assigned patent for cryptocurrency system for use in gaming 12/18/20 International Game to license IP rights for Galaxis, System2Go to Modulus 12/07/20 International Game to sell Italian gaming businesses to Gamenet for EUR 1.1B 11/25/20 Elys Game Technology appoints Matteo Monteverdi CEO IGT International Game $17.90 / -0.45 (-2.45%) 01/19/21 Jefferies International Game upgraded to Buy from Hold at Jefferies 01/14/21 Truist International Game upgraded to Buy from Hold at Truist 01/12/21 Argus International Game upgraded to Buy from Hold at Argus 01/07/21 Deutsche Bank International Game price target raised to $25 from $16 at Deutsche Bank IGT International Game $17.90 / -0.45 (-2.45%) 11/11/20 International Game reports Q3 adjusted EPS 26, consensus (21c) 08/04/20 International Game reports Q2 adj. EPS (59c), consensus (70c) IGT International Game $17.90 / -0.45 (-2.45%) 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 11/11/20 Fly Intel: After-Hours Movers 10/14/20 Fly Intel: After-Hours Movers IGT International Game $17.90 / -0.45 (-2.45%) 10/13/20 $560K strangle seller in International Game Tech with bullish bias
Hot Stocks	Schlumberger reports Q4 cash flow from operations $878M, free cash flow $554M 06:50 01/22/21 01/22 06:50 01/22/21 06:50 SLB Schlumberger $24.18 / -1.16 (-4.58%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SLB Schlumberger $24.18 / -1.16 (-4.58%) 01/11/21 Schlumberger announces European Commission approval for formation of Genvia JV 10/16/20 Schlumberger falls -7.8% 10/16/20 Schlumberger: Conditions set for continued momentum in North America in Q4 10/16/20 Schlumberger says cost-reduction program to remove $1.5B of structural costs SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/18/20 JPMorgan Schlumberger price target raised to $21 from $19 at JPMorgan 12/15/20 Citi Schlumberger price target raised to $30 from $25 at Citi 12/10/20 HSBC Schlumberger downgraded to Reduce from Hold at HSBC 11/30/20 Susquehanna Susquehanna raises targets across Oilfield Services on cyclical rebound SLB Schlumberger $24.18 / -1.16 (-4.58%) 06:50 Today Schlumberger reports Q4 adjusted EPS 22c, consensus 17c 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/16/20 Schlumberger reports Q3 adjusted EPS 16c, consensus 12c SLB Schlumberger $24.18 / -1.16 (-4.58%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says SLB Schlumberger $24.18 / -1.16 (-4.58%) 10/16/20 Fly Intel: Pre-market Movers 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 09/01/20 Fly Intel: Wall Street's top stories at midday 07/24/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 08:30 Today Schlumberger - SLB SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/10/20 Schlumberger call volume above normal and directionally bullish 11/16/20 Schlumberger call volume above normal and directionally bullish 10/16/20 Unusually active option classes on open October 16th 10/08/20 Schlumberger call volume above normal and directionally bullish

Recommendations	Appian price target raised to $100 from $80 at Morgan Stanley » 06:50 01/22/21 01/22 06:50 01/22/21 06:50 APPN Appian $184.42 / +2.33 (+1.28%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options APPN Appian $184.42 / +2.33 (+1.28%) 12/08/20 Appian RPA receives FedRAMP certification 12/08/20 Appian, Accenture Federal Services announce collaboration 10/12/20 Volkswagen Group of America deploys Appian workforce safety solution APPN Appian $184.42 / +2.33 (+1.28%) 01/19/21 Needham Appian price target raised to $193 from $94 at Needham 01/06/21 Macquarie Appian initiated with an Underperform at Macquarie 12/01/20 Barclays Barclays downgrades Appian to Underweight on 'unwarranted' 121% rally 12/01/20 Barclays Appian downgraded to Underweight from Equal Weight at Barclays APPN Appian $184.42 / +2.33 (+1.28%) 11/05/20 Appian sees FY20 EPS (42c)-(40c), consensus (57c) 11/05/20 Appian sees Q4 EPS (18c)-(16c), consensus (15c) 11/05/20 Appian reports Q3 EPS 0c, consensus (17c) 08/06/20 Appian sees Q3 EPS (18c)-(16c), consensus (19c) 29 May 02/18/21 Appian - APPN APPN Appian $184.42 / +2.33 (+1.28%) 12/22/20 Largest borrow rate increases among liquid names 10/26/20 Largest borrow rate increases among liquid names
Earnings	Schlumberger reports Q4 adjusted EPS 22c, consensus 17c » 06:50 01/22/21 01/22 06:50 01/22/21 06:50 SLB Schlumberger $24.18 / -1.16 (-4.58%) Reports Q4 revenue $5.5B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SLB Schlumberger $24.18 / -1.16 (-4.58%) 01/11/21 Schlumberger announces European Commission approval for formation of Genvia JV 10/16/20 Schlumberger falls -7.8% 10/16/20 Schlumberger: Conditions set for continued momentum in North America in Q4 10/16/20 Schlumberger says cost-reduction program to remove $1.5B of structural costs SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/18/20 JPMorgan Schlumberger price target raised to $21 from $19 at JPMorgan 12/15/20 Citi Schlumberger price target raised to $30 from $25 at Citi 12/10/20 HSBC Schlumberger downgraded to Reduce from Hold at HSBC 11/30/20 Susquehanna Susquehanna raises targets across Oilfield Services on cyclical rebound SLB Schlumberger $24.18 / -1.16 (-4.58%) 01/21/21 Notable companies reporting before tomorrow's open 01/21/21 Notable companies reporting before tomorrow's open 10/16/20 Schlumberger reports Q3 adjusted EPS 16c, consensus 12c 10/15/20 Notable companies reporting before tomorrow's open SLB Schlumberger $24.18 / -1.16 (-4.58%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says SLB Schlumberger $24.18 / -1.16 (-4.58%) 10/16/20 Fly Intel: Pre-market Movers 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 09/01/20 Fly Intel: Wall Street's top stories at midday 07/24/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit 08:30 Today Schlumberger - SLB SLB Schlumberger $24.18 / -1.16 (-4.58%) 12/10/20 Schlumberger call volume above normal and directionally bullish 11/16/20 Schlumberger call volume above normal and directionally bullish 10/16/20 Unusually active option classes on open October 16th 10/08/20 Schlumberger call volume above normal and directionally bullish
Recommendations	Keysight Technologies price target raised to $175 from $130 at Citi » 06:50 01/22/21 01/22 06:50 01/22/21 06:50 KEYS Keysight Technologies $146.68 / -0.91 (-0.62%) Citi analyst Jim Suva… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options KEYS Keysight Technologies $146.68 / -0.91 (-0.62%) 01/19/21 Keysight's edge-to-core portfolio selected by Radisys 11/24/20 Keysight Technologies CEO sells 103.5K shares of common stock 11/18/20 Keysight Technologies authorizes up to $750M share repurchase program 10/01/20 Keysight Technologies announces Satish Dhanasekaran as COO, CTO to retire KEYS Keysight Technologies $146.68 / -0.91 (-0.62%) 01/15/21 UBS Keysight Technologies price target raised to $170 from $145 at UBS 01/14/21 Barclays Keysight Technologies price target raised to $161 from $135 at Barclays 11/19/20 Baird Keysight Technologies price target raised to $126 from $112 at Baird 11/19/20 Barclays Keysight Technologies price target raised to $135 from $128 at Barclays KEYS Keysight Technologies $146.68 / -0.91 (-0.62%) 11/18/20 Keysight Technologies sees Q1 adjusted EPS $1.32-$1.38, consensus $1.25 11/18/20 Keysight Technologies reports Q4 adjusted EPS $1.62, consensus $1.46 08/20/20 Keysight Technologies sees Q4 adjusted EPS $1.42-$1.48, consensus $1.24 08/20/20 Keysight Technologies reports Q3 adjusted EPS $1.19, consensus 83c KEYS Keysight Technologies $146.68 / -0.91 (-0.62%) 08/20/20 Fly Intel: After-Hours Movers 08/13/20 Fly Intel: Wall Street's top stories for Thursday 08/13/20 Fly Intel: Wall Street's top stories at midday KEYS Keysight Technologies $146.68 / -0.91 (-0.62%) 08/20/20 Keysight Technologies options imply 5.6% move in share price post-earnings
Hot Stocks	Haemonetics supports new FDA guidance on viscoelastic testing » 06:48 01/22/21 01/22 06:48 01/22/21 06:48 HAE Haemonetics $117.90 / -6.68 (-5.36%) Haemonetics affirmed its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events HAE Haemonetics $117.90 / -6.68 (-5.36%) 01/20/21 Haemonetics acquires Cardiva Medical for over $475M 10/21/20 Haemonetics rises 11.8% 10/04/20 Haemonetics receives FDA clearance for NexSys PCS with Persona technology 08/04/20 Haemonetics falls -11.1% HAE Haemonetics $117.90 / -6.68 (-5.36%) 01/21/21 Barrington Haemonetics downgraded to Market Perform from Outperform at Barrington 01/21/21 JMP Securities Haemonetics price target raised to $140 from $110 at JMP Securities 11/05/20 Barrington Haemonetics upgraded to Outperform from Market Perform at Barrington 07/01/20 Raymond James Haemonetics price target lowered to $113 from $125 at Raymond James HAE Haemonetics $117.90 / -6.68 (-5.36%) 11/04/20 Haemonetics reports Q2 adj. EPS 62c, consensus 51c 08/04/20 Haemonetics reports Q1 adj. EPS 46c, consensus 41c 02/02/21 Haemonetics - HAE
Initiation	Public Storage resumed with an Equal Weight at Morgan Stanley » 06:48 01/22/21 01/22 06:48 01/22/21 06:48 PSA Public Storage / + Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PSA Public Storage / + 01/05/21 Public Storage enters cooperation agreement with Elliott, changes board 12/14/20 Public Storage issues statement in response to letter from Elliott Associates 12/14/20 Elliott nominates six independent candidates to Public Storage board 12/14/20 Public Storage confirms six board nominations by Elliott PSA Public Storage / + 12/31/20 Truist Public Storage price target raised to $233 from $205 at Truist 12/09/20 Morgan Stanley Public Storage price target raised to $221 from $203 at Morgan Stanley 10/06/20 Raymond James Public Storage downgraded to Underperform from Market Perform at Raymond James 10/06/20 Raymond James Public Storage downgraded to Underperform from Market Perform at Raymond James PSA Public Storage / + 11/04/20 Public Storage reports Q3 core FFO $2.63, consensus $2.60 11/04/20 Public Storage reports Q3 core FFO $2.63, consensus $2.60 08/05/20 Public Storage reports Q2 core FFO $2.46, consensus $2.52 PSA Public Storage / + 12/13/20 Elliott built stake in Public Storage, nominated six to board, WSJ reports PSA Public Storage / + 12/31/20 Alphabet, Nordstrom target changes among today's top calls on Wall Street PSA Public Storage / + 12/14/20 Early notable gainers among liquid option names on December 14th

Events

Earnings calls, analyst events, roadshows and more

TBK
Today at 08:00

Triumph Bancorp - TBK Conference Calls
PPG
Today at 08:00

PPG - PPG Conference Calls
EDU
Today at 08:00

New Oriental Education - EDU Conference Calls
HBAN
Today at 08:30

Huntington Bancshares - HBAN Conference Calls
SLB
Today at 08:30

Schlumberger - SLB Conference Calls
BMTC
Today at 08:30

Bryn Mawr Bank - BMTC Conference Calls
KSU
Today at 08:45

Kansas City Southern - KSU Conference Calls
ALLY
Today at 09:00

Ally Financial - ALLY Conference Calls
TRST
Today at 09:00

Trustco Bank - TRST Conference Calls
DNMR
Today at 09:00

Danimer Scientific - DNMR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord Priced at: $49.61 2.013M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright Priced at: $1.925 51.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley $4.75-4.95 11.5M Shares PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities $13.00-14.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright $7.50-8.00
Fri	No deals

View All Syndicate Announcements »

Reckitt Benckiser management to meet virtually with JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access